M3 Community

12/16/2025

Discover the latest available surveys, take part in healthcare market research today:
http://m3gr.io/ASCZBPI

12/16/2025

A large prospective study published in JAMA Oncology found that higher consumption of ultra-processed foods is associated with an increased risk of early-onset colorectal adenomas in women under 50, reinforcing calls to reduce UPF intake to curb rising cancer rates.

Source: Physician's Weekly

https://bit.ly/3MAhTXb

New study reveals a 45% increased risk for early-onset colorectal adenomas with high UPF consumption.

12/15/2025

Now being explored across multiple medical specialities, digital twins support predictive analytics and more personalised care, helping clinicians improve decision-making and patient pathways. As adoption grows, this technology is beginning to transform how healthcare is delivered. Link in the comments to learn more.

12/15/2025

Michigan State University researchers have developed highly accurate, beating human heart organoids that can be engineered to replicate atrial fibrillation, opening the door to studying the condition and testing new treatments after decades of limited progress.

Source: Medical Xpress - Medical and Health News

https://bit.ly/4oQukvz

Though an estimated 60 million people around the world have atrial fibrillation, or A-fib, a type of irregular and often fast heartbeat, it's been at least 30 years since any new treatments have been developed. This is because researchers haven't had accurate models of the human heart to study. Than...

12/12/2025

Universal Health Coverage Day – December 12

Universal Health Coverage (UHC) means that all people can access quality health services when and where they need them, without suffering financial hardship.

On this day, we join the global call to strengthen health systems, protect the most vulnerable, and ensure health equity for every community.

12/11/2025

A new European Heart Journal study highlights a significant but often overlooked danger: people with Type 1 and Type 2 diabetes face an elevated risk of sudden cardiac death, even in the absence of diagnosed heart disease. Researchers found that current prevention strategies fail to account for this vulnerable population, leading to missed opportunities for early detection and intervention. The findings underscore the urgent need for improved risk assessment and tailored preventive measures for individuals living with diabetes.
Source: News Medical

https://bit.ly/48pSGHr

A Danish nationwide study found that people with type 1 and type 2 diabetes have markedly higher rates of sudden cardiac death than the general population, especially at younger ages. At age 30, people with diabetes lose many years of life, with several of those years specifically attributable to su...

12/10/2025

Digital twin technology is becoming a practical reality in modern healthcare.
Discover how likely clinicians are to adopt digital twin technology:
http://m3gr.io/BGBZKUB

Digital twins in healthcare use advanced digital twins technology to enhance clinical decision-making, shaping the future of emerging healthcare technology.

12/10/2025

A major multicenter trial published in The New England Journal of Medicine found that noninvasive blood pressure monitoring using an automated brachial cuff is noninferior to early arterial catheterization for patients with shock. Survival rates at 28 days were comparable between both strategies, while the noninvasive approach led to notably fewer catheter-related complications. Researchers say these findings support safely replacing invasive monitoring in most shock cases, reducing risk without compromising outcomes.

Source: Physician's Weekly

https://www.physiciansweekly.com/post/in-shock-noninvasive-bp-monitoring-matches-arterial-catheterization

New data suggests comparable accuracy between noninvasive and invasive BP assessment in shock.

12/09/2025

Join our community of physicians helping shape the future of healthcare through paid surveys, interviews, and focus groups.

✔️ Share your expertise
✔️ Influence new treatments & innovations
✔️ Earn honoraria for your time

Make an impact beyond your practice; your insights drive real change.

12/09/2025

Chronic kidney disease often develops silently, with up to 90% of early-stage cases going undiagnosed. Because early CKD symptoms mimic everyday fatigue and common ailments, many individuals remain unaware until irreversible damage occurs. As kidney function declines quietly, routine blood and urine tests remain the strongest tools for early detection. Increasing awareness of these subtle warning signs could help save millions from preventable progression.

Source: Medical Daily

https://bit.ly/3Mm3TQM

Learn more about silent kidney disease signs, chronic kidney symptoms, and kidney failure early signs that are often ignored.

12/08/2025

Discover the latest available surveys on M3 Blog. Link in the first comment⬇️

12/08/2025

New research from Karolinska Institutet reveals that less can truly be more in melanoma treatment. A lower dose of the approved immunotherapy ipilimumab led to better tumor response, longer progression-free survival, and significantly improved overall survival compared to the traditional dose. This breakthrough could reshape treatment strategies and reduce side effects for patients battling advanced malignant melanoma.

New research from Karolinska Institutet reveals that less can truly be more in melanoma treatment. A lower dose of the approved immunotherapy ipilimumab led to better tumor response, longer progression-free survival, and significantly improved overall survival compared to the traditional dose. This breakthrough could reshape treatment strategies and reduce side effects for patients battling advanced malignant melanoma.

Source: Medical Xpress - Medical and Health News

https://bit.ly/4ppCk7T

According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National Cancer Institute.